Healthy and medically stable participants who are determined by medical history, physical examination (if clinically required), and clinical judgment of the investigator to be eligible for inclusion in the study.
You may not be if
Tested positive for influenza ≤5 months (150 days) prior to Visit 1 (Day 1).
Vaccination with any investigational or licensed influenza vaccine ≤5 months (150 days) before Visit 1 (Day 1).
Receipt of antiviral therapies for influenza (eg, Tamiflu) ≤5 months (150 days) prior to Visit 1 (Day 1).
Clareo Health | A Study to Learn About mRNA Vaccines Against Influenza in Adults
